Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
acetylcholine
adverse drug reaction
agitation
agitation, childhood, acute
akineton
alpha methyldopa hydrazine
amantadine
aminoglycoside
amitriptyline
amphetamines
ampicillin
anesthesia, general
anterocollis
antiarrhythmic drugs
antibiotics
antibiotics, neurologic complications with
anticholinergic drugs
anticholinergic drugs, side effects of
anticholinergic poisoning
anticholinesterase
anticonvulsants
anticonvulsants, untoward effects of
antidepressant
antiemetic
antihistamines
artane
atropine
atropine psychosis
autonomic dysfunction
belladonna
beta adrenergic blocker
bradykinesia
brain damage
calcium antagonist
carbidopa
catatonia
catatonia, lethal
children
chloroquine
chlorpromazine
chorea
ciprofloxacin
clozapine
cogentin
coma
complications
confusion
confusional state, acute
constipation
contrast agents, neurotoxicity of
cooling therapy
creatine phosphokinase(CPK)elevated
cyproheptidine
dehydration
delirium
dementia
deprenyl
dilantin
dopamine
dopamine agonist
dopamine antagonist
drug abuse
drug abuse, neurologic complications of
drug induced neurologic disorders
drug overdose
drug withdrawal
dyskinesia
dystonia
dystonia, cervical
dystonia, drug induced
dystonia, face
dystonia, focal
dystonia, treatment of
dystonia, truncal
dystonic reaction, acute
emergencies, medical
emergencies, neurologic
enzyme inhibition
erythromycin
exercise
fever
fluoroquinolones
grasping
hallucination
hallucination, visual
haloperidol
heatstroke
herbs
hyperthermia
iatrogenic neurologic disorders
imipramine
interferon
L-dopa
L-dopa, controlled release
L-dopa, drug interactions with and side effects of
L-dopa, potentiators of
leukocytosis
levonorgestrel
lithium
livedo reticularis
liver function enzymes
malignant hyperpyrexia
memory, defect of recent
memory, impairment of
mental status, abnormal
methacholine
migraine
migraine, prophylaxis
misdiagnosis
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, extrapyramidal-treatment of
movement disorder, treatment of
myasthenia gravis
myasthenia gravis, drug induced
myasthenia gravis, unmasked
myasthenic syndrome
myoglobinuria
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neuromuscular blockade
nicotine
obesity
old age, neurology of
orthostatic hypotension
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, fluctuations in
Parkinson disease, misdiagnosis
Parkinson disease, on-off phenomena in
Parkinson disease, treatment of
parsidol
patient information and support
penicillamine
personality change
phenothiazine
physostigmine
Pisa syndrome
poison, neurologic problems with
prevention of neurologic disorders
procyclidine
prognosis
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychosis, acute
pupil, abnormality in neurologic disorders
pupil, dilated, bilateral
pyridoxine
quinidine
renal failure
reserpine and reserpine like drugs
retrocollis
review article
rhabdomyolysis
rigidity
risk factors
ritalin
schizophrenia
seizure
serotonin syndrome
sinemet
skin, dry
steroid
tachycardia
tardive dystonia
tea
timolol
toxins, nervous system
tranquilizers, neurologic complications with
treatment of neurologic disorder
tremor
tricyclic antidepressant
verapamil
vertigo
vertigo, treatment of
vision, blurred
vitamin, multiple
xerostomia
Showing articles 1100 to 1150 of 8417 << Previous Next >>

Differential Features of Carotid and Vertebral Artery Dissections
Neurol 77:1174-1181, Debette, S.,et al, 2011

Treatment of Severe Neurological Deficits with IgG Depletion through Immunoadsorption in Patients with Escherichia coli O104:H4-Associated Haemolytic Uraemic Syndrome: A Prospective Trial
Lancet 378:1166-1173,1120, Greinacher, A.,et al, 2011

Efficacy and Safety of Combination Antiplatelet Therapies in Patients with Symptomatic Intracranial Atherosclerotic Stenosis
Stroke 42:2883-2890, Kwon, S.U.,et al, 2011

Patients with Severe Asymptomatic Carotid Artery Stenosis Do Not Have a Higher Risk of Stroke and Mortality After Coronary Artery Bypass Surgery
Stroke 42:2801-2805, Mahmoudi, M.,et al, 2011

Safety of Spinal Angiography
Neurol 77:1235-1240, Chen, J. and Gailloud P., 2011

Responsive Cortical Stimulation for the Treatment of Medically Intractable Partial Epilepsy
Neurol 77:1295-1304,e79, Morrell, M.J.,et al, 2011

Operator Experience and Carotid Stenting Outcomes in Medicare Beneficiaries
JAMA 306:1338-1343,1378, Nallamothu, B.K.,et al, 2011

Intracranial Hemorrhage Is Much More Common After Carotid Stenting Than After Endarterectomy
Stroke 42:2782-2787, McDonald, R.J.,et al, 2011

Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome)
UpToDate, Feb, Shovlin, C., 2011

Treatment of Brain Arteriovenous Malformations
JAMA 306:2011-2019, Beijnum, J.V.,et al, 2011

Evidence-based guideline update: Treatment of Essential Tremor
Neurol 77:1752-1755, Zesiewicz, T.A.,et al, 2011

Sudden, Unexpected Death in Epilepsy
NEJM 365:2902-11, Devinsky, O., 2011

Vertebral Artery Dissection Leading to Stroke Caused by Violent Neck Tics of Tourette Syndrome
Neurol 77:1706-1707, Lehman, L.L.,et al, 2011

Low-Dose Recombinant Tissue-Type Plasminogen Activator Enhances Clot Resolution in Brain Hemorrhage
Stroke 42:3009-3016,2999, Naff, N.,et al, 2011

Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011

Efficacy and Safety of Mitoxantrone in Patients with Highly Relapsing Neuromyelitis Optica
Arch Neurol 68:473-479, Kim, S.H.,et al, 2011

Folic acid supplementation prevents phenytoin-induced gingival overgrowth in children
Neurol 76:1338-1343, Arya, R.,et al, 2011

Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Neurol 76:1288-1295, Tisserand, M.,et al, 2011

Skin biopsy is useful for the antemortem diagnosis of neuronal intranuclear inclusion disease
Neurol 76:1372-1376, Sone, J.,et al, 2011

Oral vs Intratympanic Corticosteroid Therapy for Idiopathic Sudden Sensorineural Hearing Loss
JAMA 305(20):2071-2079,2114, Rauch, S.D.,et al, 2011

Are all IV thrombolysis exclusion criteria necessary? Being SMART about evidence-based medicine
Neurol 76:1780-1781, Tong, D., 2011

Safety and Outcomes of Intravenous Thrombolysis in Stroke Mimics
Stroke 42:1771-1774, Tsivgoulis, G.,et al, 2011

Comparison of IVIg and PLEX in patients with myasthenia gravis
Neurol 76:2017-2023, Barth, D.,et al, 2011

Intravenous Thrombolytic Therapy for Acute Ischemic Stroke
NEJM 364:22, Wechsler, L.R., 2011

Headache rate and cost of care following lumbar puncture at a single tertiary care hospital
Neurol 77:71-74, Dakka, Y.,et al, 2011

Clinical and MRI characteristics of acute migrainous infarction
Neurol 76:1911-1917, Wolf, M.E.,et al, 2011

Cerebral Venous Sinus Thrombosis Associated with Cerebral Hemorrhage Is Anticoagulant Treatment Safe?
The Neurologist 17:208-210, Fuentes, B.,et al, 2011

Microbleeds are Associated with Subsequent Hemorrhagic and Ischemic Stroke in Healthy Elderly Individuals
Stroke 42:1867-1871, Bokura, H.,et al, 2011

Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke
Stroke 42:1967-1970, Sarikaya, H.,et al, 2011

Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Lancet 377:2013-2022, Bousser, M.G.,et al, 2011

Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age
JNNP 82:712-717, Bhatnagar, P.,et al, 2011

Patterns and Trends in Antipsychotic Prescribing for Parkinson Disease Psychosis
Arch Neurol 68:899-904, Weintraub, D.,et al, 2011

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study
BMJ 343:d3450, Schmidt, M.,et al, 2011

Contemporary management and recent advances in paediatric hydrocephalus
BMJ 343:d4191, Kandasamy, J.,et al, 2011

Current Concepts and Management of Glioblastoma
Ann Neurol 70:9-21, Preusser, M.,et al, 2011

Apixaban in Atrial Fibrillation From Bleeding Cows to 21st Century Medicinal Chemistry
Stroke 42:2376-2378, Cucchiara, B.L.,et al, 2011

Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2333-2335, Seet, R.C.S.,et al, 2011

Impact of Obesity on Stroke Outcome After Intravenous Thrombolysis
Stroke 42:2330-2332, Sarikaya, H.,et al, 2011

Iodinated Contrast Media and Cerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2170-2174, MacDougall, N.J.J.,et al, 2011

Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis
Neurol 77:341-348, Strbian, D.,et al, 2011

Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
NEJM 364:2187-98, 2256, Smith, C.R.,et al, 2011

Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
NEJM 365:285-287, Egan, A.,et al, 2011

Ischemic Stroke and Transient Ischemic Attack After Head and Neck Radiotherapy
Stroke 42:2410-2418, Plummer, C.,et al, 2011

Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011

Safety and Functional Outcome of Thrombolysis in Dissection-Related Ischemic Stroke A Meta-Analysis of Individual Patient Data
Stroke 42:2515-2520, Zinkstok, S.M.,et al, 2011

Assessing Bioequivalence of Generic Antiepilepsy Drugs
Ann Neurol 70:221-228,192, Krauss, G.L.,et al, 2011

Azathioprine
Neurol 77:659-666, Costanzi, C.,et al, 2011

Prevention of HIV-1 Infection with Early Antiretroviral Therapy
NEJM 365:493-505,561, Cohen, M.S.,et al, 2011

Peri-ictal Pseudoprogression in Patients with Brain Tumor
Neuro Oncol 13:775-782, Rheims, S.,et al, 2011



Showing articles 1100 to 1150 of 8417 << Previous Next >>